Search results
Results from the WOW.Com Content Network
Adenosine diphosphate ( ADP) receptor inhibitors are a drug class of antiplatelet agents, used in the treatment of acute coronary syndrome (ACS) or in preventive treatment for patients who are in risk of thromboembolism, myocardial infarction or a stroke. These drugs antagonize the P2Y 12 platelet receptors and therefore prevent the binding of ...
In enzymology, a glucose-1-phosphate adenylyltransferase ( EC 2.7.7.27) is an enzyme that catalyzes the chemical reaction. Thus, the two substrates of this enzyme are ATP and alpha-D- glucose 1-phosphate, whereas its two products are diphosphate and ADP-glucose . This enzyme belongs to the family of transferases, specifically those transferring ...
In 1961, the company changed its name to Automatic Data Processing, Inc. (ADP), and began using punched card machines, check printing machines, and mainframe computers. ADP went public in 1961 with 300 clients, 125 employees, and revenues of approximately US$400,000. [3] The company established a subsidiary in the United Kingdom in 1965.
AOL is a leading online service provider that offers free email, news, entertainment, and more. With AOL, you can access your email from any device, customize your inbox, and enjoy a secure and reliable email experience. Sign in to AOL today and discover the benefits of AOL Mail.
Adenosine diphosphate ribose (ADPR) is an ester molecule formed into chains by the enzyme poly ADP ribose polymerase. ADPR is created from cyclic ADP-ribose (cADPR) by the CD38 enzyme using nicotinamide adenine dinucleotide (NAD +) as a cofactor. ADPR binds to and activates the TRPM2 ion channel. ADPR is the most potent agonist of the TRPM2 ...
The transporter is an obligate exchange translocase specific for ATP and ADP. It functions to take up ATP from the eukaryotic cell cytoplasm into the bacterium in exchange for ADP. The ATP/ADP uniporters can also transport inorganic phosphate, but not ribonucleoside and monophosphates, as well as deoxyribonucleotides. [3] [4]
Hypertrophic cardiomyopathy ( HCM, or HOCM when obstructive) is a condition in which muscle tissues of the heart become thickened without an obvious cause. [8] The parts of the heart most commonly affected are the interventricular septum and the ventricles. [10]
The enzyme ADP-phosphoglycerate phosphatase (EC 3.1.3.28) catalyzes the reaction. This enzyme belongs to the family of hydrolases, specifically those acting on phosphoric monoester bonds. The systematic name is 3- (ADP)-2-phosphoglycerate phosphohydrolase. This enzyme is also called adenosine diphosphate phosphoglycerate phosphatase .